Bluejay Diagnostics (BJDX) Research & Development (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Research & Development of $811837.0 for Q1 2026, up 3.45% on a YoY basis from $784800.0 in Q1 2025, and up 38.5% sequentially from $586144.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Research & Development (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 7 years of Research & Development data on file, last reported at $811837.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 3.45% year-over-year to $811837.0; the trailing twelve-month figure through Mar 2026 stood at $3.1 million (up 5.15% YoY), and the FY2025 full-year result was $3.0 million, down 12.25% from the prior year.
- Research & Development rose to $811837.0 in Q1 2026, from $586144.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $1.7 million in Q2 2023 to a low of $53685.0 in Q1 2022.
- A 5-year average of $973933.1 and a median of $889896.0 in 2025 frame the typical range for Research & Development.
- Across the five-year window, Research & Development surged 2423.14% in 2023 and sank 60.52% in 2024, its largest moves.
- Tracing BJDX's Research & Development over 5 years: stood at $1.3 million in 2022, then declined by 2.65% to $1.3 million in 2023, then slumped by 56.94% to $553997.0 in 2024, then advanced by 5.8% to $586144.0 in 2025, then jumped by 38.5% to $811837.0 in 2026.
- Business Quant data shows BJDX's Research & Development at $811837.0 in Q1 2026, $586144.0 in Q4 2025, and $785608.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 811,837.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 811,837.00 |
| Dec 31, 2025 | 586,144.00 |
| Sep 30, 2025 | 785,608.00 |
| Jun 30, 2025 | 889,896.00 |
| Mar 31, 2025 | 784,800.00 |
| Dec 31, 2024 | 553,997.00 |
| Sep 30, 2024 | 551,655.00 |
| Jun 30, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 756,283.00 |
| Mar 31, 2022 | 53,685.00 |
| Dec 31, 2021 | -402,976.00 |
| Sep 30, 2021 | 442,527.00 |
| Jun 30, 2021 | 225,992.00 |